FDA Inspection
WuXi Advanced TherapiesWuXi Advanced Therapies – FDA Inspection, Apr 17, 2015
Record Details
This FDA Inspection record concerns WuXi Advanced Therapies, with an inspection on April 17, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- WuXi Advanced Therapies
- Inspection Date
- April 17, 2015
- Product Type
- Drugs
View Company Profile
ID · c0b6184b-9c4a-43f0-b96a-8c40e321304f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 921995
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.160(a)Deviations from laboratory control requirements
- 21 CFR 211.194(a)Complete test data included in records
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of WuXi Advanced Therapies
7| Date | Classification | Office | Project area |
|---|---|---|---|
| November 25, 2025 | Not classified | Philadelphia District Office | |
| February 7, 2025 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 1, 2023 | Not classified | Philadelphia District Office | |
| January 22, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 12, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for WuXi Advanced Therapies
- FDA Inspection 1299454 - 2025-11-25
- FDA Inspection 1262215 - 2025-02-07
- FDA Inspection 1230154 - 2023-09-01
- FDA Inspection 1121335 - 2020-01-22
- FDA Inspection 849366 - 2013-09-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.